Skip to main content

Table 3 Questions included in the electronical questionnaire

From: Introduction of a prognostic biomarker to strengthen risk stratification of acutely admitted patients: rationale and design of the TRIAGE III cluster randomized interventional trial

Did you see the suPAR level of your patient?

 

Did you feel informed in the prognostic ability of suPAR?

 

How often did you include suPAR in your combined assessment of your patient?

 

How often did the suPAR level influence your clinical decision?

 

How often were you surprised of a high suPAR level?

 

How often were you surprised of a low suPAR level?

 
  1. SuPAR soluble urokinase plasminogen activator receptor
Back to article page

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

ISSN: 1757-7241